DeepMed Research

MONTEFIORE MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.montefiore.org

Clinical Trials

Dupilumab Treatment Effects in an Ethnically Diverse Population With Chronic Rhinosinusitis With Nasal Polyposis

Recruiting

Conditions: Chronic Rhinosinusitis With Nasal Polyps

Interventions: Biological: Dupilumab

First Posted Date: 2022-02-18

Last Posted Date: 2024-05-10

Lead Sponsor: Montefiore Medical Center

Target Recruit Count: 60

Registration Number: NCT05246267

Locations: 🇺🇸
Montefiore Medical Center, Bronx, New York, United States

A Randomized Trial of NSAID Dosing Strategies

Phase 4

Completed

Conditions: Acute Pain
Musculoskeletal Pain

Interventions: Drug: NSAID

First Posted Date: 2022-02-15

Last Posted Date: 2023-08-15

Lead Sponsor: Montefiore Medical Center

Target Recruit Count: 407

Registration Number: NCT05239767

Locations: 🇺🇸
Montefiore, Bronx, New York, United States

Suprainguinal Fascia Iliaca Compartment Block in Direct Anterior Approach to Total Hip Arthroplasty

Not Applicable

Withdrawn

Conditions: Anesthesia, Local
Block

Interventions: Other: Placebo
Procedure: Suprainguinal fascia ilica block

First Posted Date: 2022-02-14

Last Posted Date: 2022-10-04

Lead Sponsor: Montefiore Medical Center

Registration Number: NCT05237479

Scalp Cooling for Chemotherapy-Induced Alopecia in Patients of Color

Not Applicable

Recruiting

Conditions: Alopecia

Interventions: Device: Scalp cooling with hairstyle
Device: Scalp cooling with conditioner and water emulsion

First Posted Date: 2022-01-28

Last Posted Date: 2025-01-15

Lead Sponsor: Montefiore Medical Center

Target Recruit Count: 30

Registration Number: NCT05213936

Locations: 🇺🇸
Montefiore Medical Center, Bronx, New York, United States

Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML

Phase 2

Recruiting

Conditions: CMML
AML
MDS

Interventions: Drug: Venetoclax
Drug: Decitabine

First Posted Date: 2022-01-11

Last Posted Date: 2024-06-18

Lead Sponsor: Montefiore Medical Center

Target Recruit Count: 85

Registration Number: NCT05184842

Locations: 🇺🇸
Montefiore Medical Center, Bronx, New York, United States

Targeting Bias to Reduce Disparities in End of Life Care

Not Applicable

Completed

Conditions: Critical Illness
Terminal Illness

Interventions: Behavioral: Communication skills training
Behavioral: Communication and Bias Mitigation Training

First Posted Date: 2021-12-21

Last Posted Date: 2025-04-02

Lead Sponsor: Montefiore Medical Center

Target Recruit Count: 22

Registration Number: NCT05165888

Locations: 🇺🇸
Montefiore Medical Center, Bronx, New York, United States

Preoperative Mindfulness: Minimally Invasive Hysterectomy

Not Applicable

Recruiting

Conditions: Pain, Postoperative

Interventions: Behavioral: Mindfulness training

First Posted Date: 2021-12-15

Last Posted Date: 2025-03-14

Lead Sponsor: Montefiore Medical Center

Target Recruit Count: 72

Registration Number: NCT05157490

Locations: 🇺🇸
Montefiore Medical Center-Albert Einstein College of Medicine, Bronx, New York, United States

Updated Diagnostic Cortisol Values for Adrenal Insufficiency

Not Applicable

Recruiting

Conditions: Adrenal Insufficiency

Interventions: Diagnostic Test: Cosyntropin stimulation test

First Posted Date: 2021-12-08

Last Posted Date: 2024-12-27

Lead Sponsor: Montefiore Medical Center

Target Recruit Count: 90

Registration Number: NCT05149638

Locations: 🇺🇸
Montefiore Medical Center, Bronx, New York, United States

Thulium Laser and Topical Platelet Rich Plasma (PRP) vs. PRP Injection for the Treatment of Male Androgenetic Alopecia

Not Applicable

Withdrawn

Conditions: Androgenetic Alopecia

Interventions: Device: Fractionated Thulium laser
Procedure: Autologous Platelet Rich Plasma Injection
Procedure: Autologous Platelet Rich Plasma Topical Application

First Posted Date: 2021-11-22

Last Posted Date: 2022-08-05

Lead Sponsor: Montefiore Medical Center

Registration Number: NCT05129254

Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization

Phase 4

Active, not recruiting

Conditions: Substance Use Disorders
Opioid-use Disorder
Chronic Pain

Interventions: Drug: BUP microdose induction
Drug: TAU
Behavioral: Linkage to outpatient BUP treatment

First Posted Date: 2021-11-11

Last Posted Date: 2024-12-18

Lead Sponsor: Montefiore Medical Center

Target Recruit Count: 23

Registration Number: NCT05118204

Locations: 🇺🇸
Montefiore Medical Center, Bronx, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy